©
Oxford Mail
MiroBio, a University of Oxford spin-out, started its operations at the BioEscalator in May 2019. The company was spun out from the laboratories of Simon Davis, Professor of Molecular Immunology at the MRC Weatherall Institute of Molecular Medicine, and Richard Cornall, Nuffield Professor of Clinical Medicine at the University of Oxford.
Initially, MiroBio is focused on autoimmune diseases and opportunistically exploring other disease areas. The team has achieved significant results in the lab and recently secured £27 million in series A funding from international investors, allowing the company to expand its team and operations. As a result of this growth, MiroBio has outgrown the BioEscalator and has relocated to The Oxford Science Park, joining a community of innovative companies, including other BioEscalator alums.
Tim Funnell, VP, Operations of MiroBio, said: “The BioEscalator is a buzzing community of ambitious start-up biotech's and welcomed MiroBio when we were a team of just 2 people in 2019. The high-quality facilities, resources and support to grow a company were invaluable and we are now graduating as a company of 15 scientists to build our independent laboratories.”
More details about MiroBio's relocation to The Oxford Science Park